Cytovale: Christopher Slachta
Cytovale has appointed Christopher Slachta the firm's chief operating officer. He has more than two decades of experience in the medical device and diagnostic industry, and before joining Cytovale, Slachta spent 12 years at Abbott, most recently as divisional VP of global operations and supply chain, molecular diagnostics. Before that, he led manufacturing operations at Ortho Clinical Diagnostics, where he was GM for five Johnson & Johnson medical devices and diagnostics manufacturing sites. Last summer San Francisco-based Cytovale said it was preparing to launch its IntelliSep prognostic blood-based sepsis test, which can be used to identify patients at the highest risk of developing sepsis.